title: Do bone morphogenic protein-4 antagonists have any role in the treatment of human hypertension?
authors: Ekrem
authors: E
authors: Yeter
authors: Mustafa
authors: M
authors: Kurt
authors: Bülent
authors: B
authors: Ozçakar
authors: Ali E
authors: AE
authors: Denktaş
mesh_terms: D000959:Antihypertensive Agents / Q000378:metabolism / Q000627:therapeutic use*; D001783:Blood Flow Velocity / Q000187:drug effects; D055415:Bone Morphogenetic Protein 4 / Q000037:antagonists & inhibitors* / Q000378:metabolism / Q000627:therapeutic use*; D004730:Endothelium, Vascular / Q000187:drug effects* / Q000378:metabolism; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D009131:Muscle, Smooth, Vascular / Q000187:drug effects / Q000378:metabolism; D012039:Regional Blood Flow / Q000187:drug effects
chemical_list: D000959:Antihypertensive Agents; D055415:Bone Morphogenetic Protein 4